Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Circulating 11-oxygenated androgens predict survival in localized prostate cancer
In men with localized prostate cancer undergoing radical prostatectomy and treated with 5α-reductase inhibitor (5-ARI), preoperative levels of circulating 11-oxygenated androgens can indicate either disease progression or improved survival, a recent study has found.
Circulating 11-oxygenated androgens predict survival in localized prostate cancer
01 Feb 2023
Pharmacist-led intervention improves BP control of patients on oral chemotherapy
Patients on oral chemotherapy, who underwent a pharmacist-led hypertension management program, show improvements in blood pressure (BP) control as well as lower mean BP readings over time, reports a recent study.
Pharmacist-led intervention improves BP control of patients on oral chemotherapy
28 Jan 2023
Objective response to systemic therapy linked to overall survival in unresectable HCC
Objective response to first-line systemic therapy with lenvatinib or sorafenib independently predicts overall survival (OS) in individuals with unresectable hepatocellular carcinoma (HCC), as shown by the subanalysis of the REFLECT study.
Objective response to systemic therapy linked to overall survival in unresectable HCC
23 Jan 2023
Multiple moles, genetic predisposition up risk of second primary melanomas
Individuals with multiple nevi and high genetic predisposition to melanoma appear to have the highest risks of developing second primary melanomas, according to a study.
Multiple moles, genetic predisposition up risk of second primary melanomas
22 Jan 2023
Trastuzumab deruxtecan confers hope as second-line therapy for HER2+ mBC
Updated results of the DESTINY-Breast03 trial, presented at SABCS 2022, showed that in patients with HER2+ metastatic breast cancer, second-line treatment with trastuzumab deruxtecan conferred better survival benefits than treatment with trastuzumab emtansine.